Literature DB >> 15920064

Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function.

Stewart C Ferguson1, Annette Blane, Joanna Wardlaw, Brian M Frier, Petros Perros, Rory J McCrimmon, Ian J Deary.   

Abstract

OBJECTIVE: Children who develop type 1 diabetes before age 7 years (early-onset diabetes; EOD) have comparatively poorer cognitive abilities. Whether this relates to psychosocial consequences of chronic illness or organic factors related to diabetes and its complications remains unresolved. We hypothesized that if differences in neuroradiological structure and cognitive ability coexisted in those who had EOD, then an organic component to their etiology was likely. RESEARCH DESIGN AND METHODS: A cohort of 71 young adults with long-duration type 1 diabetes diagnosed during childhood or adolescence participated in a cross-sectional evaluation of cognitive ability (neuropsychological test battery) and brain structure (magnetic resonance imaging). Diabetes onset age, preceding severe hypoglycemia exposure, retinopathy status, and diabetes duration were examined as potential correlates of cognitive and neuroradiological differences. No participants had previous neuropsychological pathology.
RESULTS: In EOD participants (n = 26), current intellectual ability (Wechsler Adult Intelligence Scale-Revised performance IQ; P = 0.03) and information processing ability (Choice Reaction Time; P = 0.006) were comparatively poorer than was observed in those with later- onset diabetes (n = 45). Furthermore, lateral ventricular volumes were 37% greater (P = 0.002) and ventricular atrophy was more prevalent (61 vs. 20%; P = 0.01) in the EOD group than in those who had later-onset type 1 diabetes.
CONCLUSIONS: An early childhood onset of type 1 diabetes was associated with mild central brain atrophy and significant differences in intellectual performance in adulthood, implying that neurodevelopment may be adversely affected by EOD. The differences observed in brain structure support an organic contribution to their etiology but do not exclude a coexistent contribution of psychosocial factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920064     DOI: 10.2337/diacare.28.6.1431

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  71 in total

1.  Neurocognitive functioning in preschool-age children with type 1 diabetes mellitus.

Authors:  Anna Maria Patiño-Fernández; Alan M Delamater; E Brooks Applegate; Erika Brady; Margaret Eidson; Robin Nemery; Luis Gonzalez-Mendoza; Samuel Richton
Journal:  Pediatr Diabetes       Date:  2010-04-23       Impact factor: 4.866

2.  Change in mean transit time, apparent diffusion coefficient, and cerebral blood volume during pediatric diabetic ketoacidosis treatment.

Authors:  Monica S Vavilala; Ken I Marro; Todd L Richards; Joan S Roberts; Parichat Curry; Catherine Pihoker; Heidi Bradford; Dennis Shaw
Journal:  Pediatr Crit Care Med       Date:  2011-11       Impact factor: 3.624

Review 3.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

4.  Managing type 1 diabetes in school: Recommendations for policy and practice.

Authors:  Sarah E Lawrence; Elizabeth A Cummings; Danièle Pacaud; Andrew Lynk; Daniel L Metzger
Journal:  Paediatr Child Health       Date:  2015 Jan-Feb       Impact factor: 2.253

5.  Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia.

Authors:  Owen T Carmichael; Lewis H Kuller; Oscar L Lopez; Paul M Thompson; Rebecca A Dutton; Allen Lu; Sharon E Lee; Jessica Y Lee; Howard J Aizenstein; Carolyn C Meltzer; Yanxi Liu; Arthur W Toga; James T Becker
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Jan-Mar       Impact factor: 2.703

6.  Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function.

Authors:  Christopher T Kodl; Daniel T Franc; Jyothi P Rao; Fiona S Anderson; William Thomas; Bryon A Mueller; Kelvin O Lim; Elizabeth R Seaquist
Journal:  Diabetes       Date:  2008-08-11       Impact factor: 9.461

7.  Ghrelin inhibits high glucose-induced PC12 cell apoptosis by regulating TLR4/NF-κB pathway.

Authors:  Xiaoyan Liu; Qian Xiao; Kexiang Zhao; Yuan Gao
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

8.  White matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetes.

Authors:  Karen A Nunley; Christopher M Ryan; Trevor J Orchard; Howard J Aizenstein; J Richard Jennings; John Ryan; Janice C Zgibor; Robert M Boudreau; Tina Costacou; John D Maynard; Rachel G Miller; Caterina Rosano
Journal:  Neurology       Date:  2015-04-22       Impact factor: 9.910

9.  Paediatric non-ketotic hyperglycaemic hemichorea-hemiballismus.

Authors:  Cezar Thomas Reyes Suratos; James Albert Edward Lim Benitez; Sheen Corvera Urquiza; Cheryl Anne Lubaton Sacro
Journal:  BMJ Case Rep       Date:  2018-04-05

10.  Persistence of abnormalities in white matter in children with type 1 diabetes.

Authors:  Larry A Fox; Tamara Hershey; Nelly Mauras; Ana Maria Arbeláez; William V Tamborlane; Bruce Buckingham; Eva Tsalikian; Kim Englert; Mira Raman; Booil Jo; Hanyang Shen; Allan Reiss; Paul Mazaika
Journal:  Diabetologia       Date:  2018-04-13       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.